See more : Third Point Investors Limited (TPOS.L) Income Statement Analysis – Financial Results
Complete financial analysis of Diamond Biotechnology Co., Ltd (6815.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Diamond Biotechnology Co., Ltd, a leading company in the None industry within the None sector.
You may be interested
- Vulcan Steel Limited (VSL.NZ) Income Statement Analysis – Financial Results
- Stadlauer Malzfabrik Aktiengesellschaft (STM.VI) Income Statement Analysis – Financial Results
- Jiangsu Huifeng Bio Agriculture Co., Ltd. (002496.SZ) Income Statement Analysis – Financial Results
- Revenue Group Berhad (0200.KL) Income Statement Analysis – Financial Results
- China Tonghai International Financial Limited (0952.HK) Income Statement Analysis – Financial Results
Diamond Biotechnology Co., Ltd (6815.TWO)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 616.10M | 434.84M | 395.20M | 306.39M | 268.35M |
| Cost of Revenue | 326.50M | 250.53M | 207.32M | 177.96M | 133.59M |
| Gross Profit | 289.59M | 184.32M | 187.88M | 128.43M | 134.77M |
| Gross Profit Ratio | 47.00% | 42.39% | 47.54% | 41.92% | 50.22% |
| Research & Development | 29.33M | 25.94M | 27.93M | 2.89M | 1.12M |
| General & Administrative | 54.75M | 47.20M | 41.64M | 34.19M | 36.44M |
| Selling & Marketing | 140.14M | 64.11M | 70.23M | 77.95M | 39.81M |
| SG&A | 194.89M | 111.31M | 111.86M | 112.14M | 77.35M |
| Other Expenses | 0.00 | -1.09M | 6.40M | 944.00K | 0.00 |
| Operating Expenses | 225.69M | 137.25M | 139.79M | 115.03M | 77.12M |
| Cost & Expenses | 552.19M | 387.78M | 347.11M | 293.00M | 210.70M |
| Interest Income | 696.00K | 429.00K | 44.00K | 53.00K | 29.00K |
| Interest Expense | 7.52M | 3.74M | 2.27M | 2.48M | 1.13M |
| Depreciation & Amortization | 50.32M | 53.48M | 58.18M | 54.82M | 22.77M |
| EBITDA | 116.17M | 99.89M | 112.72M | 69.21M | 79.07M |
| EBITDA Ratio | 18.86% | 22.97% | 28.52% | 22.59% | 29.47% |
| Operating Income | 65.37M | 46.41M | 54.54M | 14.39M | 56.30M |
| Operating Income Ratio | 10.61% | 10.67% | 13.80% | 4.70% | 20.98% |
| Total Other Income/Expenses | -7.04M | -4.40M | 4.17M | -1.48M | 246.00K |
| Income Before Tax | 58.33M | 41.82M | 52.05M | 13.51M | 56.55M |
| Income Before Tax Ratio | 9.47% | 9.62% | 13.17% | 4.41% | 21.07% |
| Income Tax Expense | 11.59M | 8.44M | 10.13M | 2.46M | 12.36M |
| Net Income | 46.74M | 33.39M | 41.92M | 11.05M | 44.18M |
| Net Income Ratio | 7.59% | 7.68% | 10.61% | 3.61% | 16.46% |
| EPS | 1.50 | 1.20 | 1.51 | 0.41 | 1.93 |
| EPS Diluted | 1.50 | 1.20 | 1.51 | 0.41 | 1.92 |
| Weighted Avg Shares Out | 31.25M | 27.82M | 27.82M | 26.93M | 22.89M |
| Weighted Avg Shares Out (Dil) | 31.26M | 27.83M | 27.83M | 26.93M | 22.98M |
No news found for: 6815.TWO
Source: https://incomestatements.info
Category: Stock Reports